1.80000 USD
0.04
2.27%
Last update Dec 18, 3:59 PM EST
Market closed
Day range
1.75
1.81000
Previous close
1.76000
Open
1.79000
Access this stock data via API
Subscribe
Protalix Biotherapeutics Inc.
1.80
0.04
2.27%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 17.9M 15.7M 10.1M 18.2M
Cost of revenue 8.3M 5.9M 8.2M 3.9M
Gross profit 9.5M 9.8M 1.9M 14.3M
Operating expense
Research & development 4.5M 6.0M 3.5M 4.1M
Selling general and admin 2.9M 2.6M 2.6M 3.0M
Other operating expenses
Operating income 2.1M 1.2M -4.1M 7.2M
Non operating interest income
Income 288K 272K 419K 113K
Expense 180K 783K 6K 6K
Other income expense
Pretax income 2.2M 661K -3.7M 7.3M
Tax provision -116K 497K -113K 822K
Net income 2.4M 164K -3.6M 6.5M
Basic EPS 0.0 0 -0.1
Diluted EPS 0.0 0 -0.1
Basic average shares 79.3M 78.7M 76.6M
Diluted average shares 80.8M 81.3M 76.6M
EBITDA 2.8M 1.8M -3.4M 7.7M
Net income from continuing op. 2.4M 164K -3.6M 6.5M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 5 hours 9 minutes

22:50
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).